| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 359,872 | 224,653 | 188,323 | 232,364 | | Cost of Revenue | 327,165 | 219,032 | 219,653 | 218,555 | | | Gross Profit | 32,707 | 5,621 | (31,330) | 13,809 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 53,483 | 51,357 | 67,030 | 56,209 | | Non Recurring |
-
|
-
|
-
| 16,143 | | Others | 5,657 | 4,957 | 4,339 | 3,783 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (26,433) | (50,693) | (102,699) | (62,326) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 70,078 | 32,844 | (15,735) | (18,279) | | Earnings Before Interest And Taxes | 44,137 | (21,890) | (126,775) | (82,018) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 44,137 | (21,890) | (126,775) | (82,018) | | Income Tax Expense | (550) | 5,990 | (12,008) | (1,963) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 44,687 | (27,880) | (114,767) | (80,055) | | | Non-recurring Events | | Discontinued Operations | (10,896) | (96) | (156) | (220) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 33,791 | (27,976) | (114,923) | (80,275) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $33,791 | ($27,976) | ($114,923) | ($80,275) |
|
0.26% Nasdaq 
0.12%
Income Statement
